Literature DB >> 29567719

The World Health Organization global aDSM database: generating evidence on the safety of new treatment regimens for drug-resistant tuberculosis.

Christine M Halleux1,2, Dennis Falzon3,2, Corinne Merle4, Ernesto Jaramillo3, Fuad Mirzayev3, Piero Olliaro4, Karin Weyer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29567719     DOI： 10.1183/13993003.01643-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.

Authors:  Gina Gualano; Paola Mencarini; Maria Musso; Silvia Mosti; Laura Santangelo; Silvia Murachelli; Angela Cannas; Antonino Di Caro; Assunta Navarra; Delia Goletti; Enrico Girardi; Fabrizio Palmieri
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

2.  Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.

Authors:  Jonathon R Campbell; Dennis Falzon; Fuad Mirzayev; Ernesto Jaramillo; Giovanni Battista Migliori; Carole D Mitnick; Norbert Ndjeka; Dick Menzies
Journal:  Emerg Infect Dis       Date:  2020-03-17       Impact factor: 6.883

3.  Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity.

Authors:  Lisa Stevens; Kelly E Perry; Iakuna Moide; Francil Kaemala; Justine Nankinga; Anh L Innes; Ignatius Mogaba
Journal:  Glob Health Sci Pract       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.